Chloropyramine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H20ClN3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2K3L8O9SOV, chemically known as 1,2-ethanediamine, n-((4-chlorophenyl)methyl)-n,n-dimethyl-n-2-pyridinyl- (9ci) but generally known as chloropyramine, which bears US NIH Compound Identifier 25295. European Medicines Agency schedules Chloropyramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06194MIG. The term CHLOROPYRAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules chloropyramine in its Anatomical Therapeutic Chemical (ATC) Classification. CHLOROPYRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chloropyramine under HS 29333999 and SITC 51574. As of Q4 2014, CHLOROPYRAMINE remains the US FDA Preferred Term for this commodity. Chloropyramine bears US NLM identifiers UMLS ID C0055445 and NCI Concept Code C81130. SMILES: CLC1CCC(CN(CCN(C)C)C2NCCCC2)CC1.